A Combination of PD-1 and TIGIT Checkpoint Blockade Elicits a Strong Antitumor Response in the Patient and Mouse Pleural Mesothelioma Model

被引:0
|
作者
Shi, H. [1 ]
Johnson, B. [1 ]
Yu, T. -K. [1 ]
Zhuang, L. [1 ]
Selvamani, S. P. [1 ]
Lee, K. [2 ]
Klebe, S. [3 ]
Chen, K. [4 ]
Clark, G. [4 ]
Kao, S. [1 ]
Silveira, P. [4 ]
Cheng, Y. Y. [5 ]
机构
[1] Asbestos Dis Res Inst, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Flinders Hlth & Med Res Inst, Adelaide, SA, Australia
[4] Anzac Res Inst, Sydney, NSW, Australia
[5] Inst Biomed Mat & Devices IBMD, Sydney, NSW, Australia
关键词
pleural mesothelioma; immune checkpoint inhibitor; mouse model;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.21-02
引用
收藏
页码:S388 / S388
页数:1
相关论文
共 50 条
  • [1] A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma
    Shi, Huaikai
    Yu, Ta-Kun
    Johnson, Ben
    Selvamani, Sakthi Priya
    Zhuang, Ling
    Lee, Kenneth
    Klebe, Sonja
    Smith, Samuel
    Wong, Kirby
    Chen, Kate
    Clark, Georgina
    Rath, Emma M.
    Pearson, Holly
    Ortega, David Gallego
    Linton, Anthony
    Kao, Steven
    Silveira, Pablo
    Cheng, Yuen Yee
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2025, 44 (01)
  • [2] TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
    Hung, Alice L.
    Maxwell, Russell
    Theodros, Debebe
    Belcaid, Zineb
    Mathios, Dimitrios
    Luksik, Andrew S.
    Kim, Eileen
    Wu, Adela
    Xia, Yuanxuan
    Garzon-Muvdi, Tomas
    Jackson, Christopher
    Ye, Xiaobu
    Tyler, Betty
    Selby, Mark
    Korman, Alan
    Barnhart, Bryan
    Park, Su-Myeong
    Youn, Je-In
    Chowdhury, Tamrin
    Park, Chul-Kee
    Brem, Henry
    Pardoll, Drew M.
    Lim, Michael
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [3] Combination of anti-TIGIT and anti-PD-1 antibodies enhance antitumor response in a PD-1/TIGIT double HuGEMM™ model engrafted with mouse syngeneic tumors
    He, Daniel Xianfei
    Nie, Chenpan
    Zheng, Lei
    Sun, Ruilin
    Zhang, Mingkun
    An, Annie Xiaoyu
    Ju, Cunxiang
    Li, Henry Q. X.
    Ouyang, Davy Xuesong
    CANCER RESEARCH, 2020, 80 (16)
  • [4] PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
    Yuan Li
    Yang Du
    Ting Sun
    Huadan Xue
    Zhengyu Jin
    Jie Tian
    BMC Cancer, 18
  • [5] PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
    Li, Yuan
    Du, Yang
    Sun, Ting
    Xue, Huadan
    Jin, Zhengyu
    Tian, Jie
    BMC CANCER, 2018, 18
  • [6] PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
    Li, Yuan
    Du, Yang
    Sun, Ting
    Xue, Huadan
    Tian, Jie
    Jin, Zhengyu
    CANCER RESEARCH, 2017, 77
  • [7] Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
    Peng, Hui
    Li, Lijin
    Zuo, Chong
    Chen, Michael Y.
    Zhang, Xiuli
    Myers, Nancy B.
    Hogg, Graham D.
    DeNardo, David G.
    Goedegebuure, S. Peter
    Hawkins, William G.
    Gillanders, William E.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
    Schmittnaegel, Martina
    Rigamonti, Nicolo
    Kadioglu, Ece
    Cassara, Antonino
    Rmili, Celine Wyser
    Kiialainen, Anna
    Kienast, Yvonne
    Mueller, Hans-Joachim
    Ooi, Chia-Huey
    Laoui, Damya
    De Palma, Michele
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (385)
  • [9] The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer
    Xu, Naijin
    Huang, Linglong
    Li, Xiezhao
    Watanabela, Masami
    Li, Chaoming
    Xu, Abai
    Liu, Chunxiao
    Li, Qiang
    Araki, Motoo
    Wada, Koichiro
    Nasu, Yasutomo
    Huang, Peng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (05): : 919 - 928
  • [10] Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
    Hayashi, Hidetoshi
    Chamoto, Kenji
    Hatae, Ryusuke
    Kurosaki, Takashi
    Togashi, Yosuke
    Fukuoka, Kazuya
    Coto, Megumi
    Chiba, Yasutaka
    Tomida, Shuta
    Ota, Takayo
    Haratani, Koji
    Takahama, Takayuki
    Tanizaki, Junko
    Yoshida, Takeshi
    Iwasa, Tsutomu
    Tanaka, Kaoru
    Takeda, Masayuki
    Hirano, Tomoko
    Yoshida, Hironori
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Sakai, Kazuko
    Higuchi, Keiko
    Uga, Hitoshi
    Suminaka, Chihiro
    Hirai, Toyohiro
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    Honjo, Tasuku
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (07):